Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-25 @ 12:58 AM
NCT ID:
NCT01155193
Eligibility Criteria:
Inclusion Criteria:
* Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the Respiratory syncytial virus season
* Children less than 2 years of age and requiring treatment for bronchopulmonary dysplasia within the last 6 months.
* Children less than 2 years of age and with hemodynamically significant congenital heart disease.
Exclusion Criteria:
* Children with known hypersensitivity to palivizumab or any component of the formulation, or other humanized monoclonal antibodies
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
24 Months
Study:
NCT01155193
Study Brief:
Protocol Section:
NCT01155193